Patients With Intransit Stage III/IV Melanoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Patients With Intransit Stage III/IV Melanoma trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (2 shown)

CompletedPhase 1

NCT01213732

Phase 1 Dose-finding Study of L19TNFα Plus Melphalan Using Isolated Inferior Limb Perfusion (ILP) in Subjects With Intra…

In this study the recombinant human fusion protein L19TNFα will be associated in ILP with the standard treatment with melphalan 10mg/l limb volume in subjects a…

Italy19 participantsStarted 2008-10

Treatment: Isolated inferior limb perfusion

TerminatedNot Applicable

NCT02716077

Early FDG PET in Melanoma

Adult patients with histologically proven melanoma who will be treated with pembrolizumab will undergo FDG PET/CT scan as an early evaluation of response to the…

United States6 participantsStarted 2016-03

Treatment: FDG PET/CT imaging